ATE447717T1 - Verfahren zum nachweis eines prokoagulierenden phospholipids - Google Patents

Verfahren zum nachweis eines prokoagulierenden phospholipids

Info

Publication number: ATE447717T1
Authority: AT; Austria
Prior art keywords: phospholipid; admixture; procoagulant; plasma; iii
Prior art date: 2003-09-22

Application number

AT04761326T

Other languages

English (en)

Inventor

Thomas Exner

Original Assignee

Haematex Res Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-22

Filing date

2004-09-22

Publication date

2009-11-15

2003-09-22 Priority claimed from AU2003905172A external-priority patent/AU2003905172A0/en

2004-09-22 Application filed by Haematex Res Pty Ltd filed Critical Haematex Res Pty Ltd

2009-11-15 Application granted granted Critical

2009-11-15 Publication of ATE447717T1 publication Critical patent/ATE447717T1/de

Links

150000003904 phospholipids Chemical class 0.000 title abstract 5
238000000034 method Methods 0.000 title abstract 3
239000003805 procoagulant Substances 0.000 abstract 4
239000000758 substrate Substances 0.000 abstract 3
ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 abstract 1
206010053567 Coagulopathies Diseases 0.000 abstract 1
102000015439 Phospholipases Human genes 0.000 abstract 1
108010064785 Phospholipases Proteins 0.000 abstract 1
230000003213 activating effect Effects 0.000 abstract 1
239000003153 chemical reaction reagent Substances 0.000 abstract 1
230000035602 clotting Effects 0.000 abstract 1
230000015271 coagulation Effects 0.000 abstract 1
238000005345 coagulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03L—AUTOMATIC CONTROL, STARTING, SYNCHRONISATION OR STABILISATION OF GENERATORS OF ELECTRONIC OSCILLATIONS OR PULSES
- H03L7/00—Automatic control of frequency or phase; Synchronisation
- H03L7/06—Automatic control of frequency or phase; Synchronisation using a reference signal applied to a frequency- or phase-locked loop
- H03L7/16—Indirect frequency synthesis, i.e. generating a desired one of a number of predetermined frequencies using a frequency- or phase-locked loop
- H03L7/22—Indirect frequency synthesis, i.e. generating a desired one of a number of predetermined frequencies using a frequency- or phase-locked loop using more than one loop

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Food Science & Technology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Biophysics (AREA)
Endocrinology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

AT04761326T 2003-09-22 2004-09-22 Verfahren zum nachweis eines prokoagulierenden phospholipids ATE447717T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AU2003905172A AU2003905172A0 (en)		2003-09-22	Method for Detecting Procoagulant Phospholipid
PCT/AU2004/001291 WO2005029093A1 (en)	2003-09-22	2004-09-22	Method for detecting procoagulant phospholipid

Publications (1)

Publication Number	Publication Date
ATE447717T1 true ATE447717T1 (de)	2009-11-15

Family

ID=34318306

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04761326T ATE447717T1 (de)	2003-09-22	2004-09-22	Verfahren zum nachweis eines prokoagulierenden phospholipids

Country Status (16)

Country	Link
US (2)	US20060228765A1 (de)
EP (1)	EP1668373B1 (de)
JP (1)	JP4559426B2 (de)
KR (1)	KR20060113662A (de)
CN (1)	CN1856710B (de)
AT (1)	ATE447717T1 (de)
BR (1)	BRPI0414293A (de)
CA (1)	CA2539034A1 (de)
DE (1)	DE602004023957D1 (de)
ES (1)	ES2333872T3 (de)
IL (1)	IL174156A0 (de)
MX (1)	MXPA06003192A (de)
NO (1)	NO20061240L (de)
RU (1)	RU2006107577A (de)
WO (1)	WO2005029093A1 (de)
ZA (1)	ZA200601974B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005028018A1 (de) *	2005-06-16	2006-12-21	Dade Behring Marburg Gmbh	Verfahren zur Standardisierung von Gerinnungstesten
IS2809B (is) *	2011-03-08	2012-10-15	Haskoli Islands	Blóðstorkumæling
WO2018109004A1 (en) *	2016-12-14	2018-06-21	Roche Diagnostics Gmbh	Determination of interferents in a sample
CN109490557A (zh) *	2018-11-23	2019-03-19	福州长庚医疗器械有限公司	一种运用血液凝固方式测量促凝剂效果的检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6248553B1 (en) *	1998-10-22	2001-06-19	Atairgin Technologies, Inc.	Enzyme method for detecting lysophospholipids and phospholipids and for detecting and correlating conditions associated with altered levels of lysophospholipids

2004
- 2004-09-22 BR BRPI0414293-4A patent/BRPI0414293A/pt not_active IP Right Cessation
- 2004-09-22 RU RU2006107577/13A patent/RU2006107577A/ru unknown
- 2004-09-22 JP JP2006527221A patent/JP4559426B2/ja not_active Expired - Fee Related
- 2004-09-22 DE DE602004023957T patent/DE602004023957D1/de not_active Expired - Lifetime
- 2004-09-22 CN CN2004800273944A patent/CN1856710B/zh not_active Expired - Fee Related
- 2004-09-22 WO PCT/AU2004/001291 patent/WO2005029093A1/en not_active Ceased
- 2004-09-22 ZA ZA200601974A patent/ZA200601974B/en unknown
- 2004-09-22 KR KR1020067005501A patent/KR20060113662A/ko not_active Ceased
- 2004-09-22 MX MXPA06003192A patent/MXPA06003192A/es not_active Application Discontinuation
- 2004-09-22 CA CA002539034A patent/CA2539034A1/en not_active Abandoned
- 2004-09-22 AT AT04761326T patent/ATE447717T1/de not_active IP Right Cessation
- 2004-09-22 ES ES04761326T patent/ES2333872T3/es not_active Expired - Lifetime
- 2004-09-22 EP EP04761326A patent/EP1668373B1/de not_active Expired - Lifetime
2006
- 2006-03-07 IL IL174156A patent/IL174156A0/en unknown
- 2006-03-17 NO NO20061240A patent/NO20061240L/no not_active Application Discontinuation
- 2006-03-21 US US11/384,258 patent/US20060228765A1/en not_active Abandoned
2009
- 2009-02-24 US US12/391,877 patent/US20090221012A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1856710B (zh)	2012-06-13
EP1668373B1 (de)	2009-11-04
WO2005029093A1 (en)	2005-03-31
EP1668373A1 (de)	2006-06-14
NO20061240L (no)	2006-05-31
MXPA06003192A (es)	2006-12-14
US20090221012A1 (en)	2009-09-03
JP4559426B2 (ja)	2010-10-06
ES2333872T3 (es)	2010-03-02
BRPI0414293A (pt)	2006-11-07
IL174156A0 (en)	2006-08-01
KR20060113662A (ko)	2006-11-02
CA2539034A1 (en)	2005-03-31
RU2006107577A (ru)	2007-10-27
ZA200601974B (en)	2007-05-30
JP2007505636A (ja)	2007-03-15
CN1856710A (zh)	2006-11-01
US20060228765A1 (en)	2006-10-12
DE602004023957D1 (de)	2009-12-17
EP1668373A4 (de)	2007-01-10

Similar Documents

Publication	Publication Date	Title
ATE440151T1 (de)	2009-09-15	Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum
JP5896764B2 (ja)	2016-03-30	直接的凝固因子阻害剤を決定するためのへパリン非感受性方法
RU2012104816A (ru)	2013-08-20	Стандартные лекарственные препараты и способы лечения тромбоза пероральным введением ингибитора фактора ха
DE69108896D1 (de)	1995-05-18	Verfahren zur bestimmung der konzentration von antikoagulantien.
DE602005013957D1 (de)	2009-05-28	Verfahren zur durchführung von vollbluttests
ATE378402T1 (de)	2007-11-15	Vorrichtung und verfahren zur herstellung von autologem thrombinserum
CN102066947A (zh)	2011-05-18	凝血时间延长原因的判定方法
ATE511549T1 (de)	2011-06-15	Kit zur messung der thrombinerzeugung in einer blut- oder plasmaprobe eines patienten
ATE465415T1 (de)	2010-05-15	Protokoll zur bestimmung von heparininduzierter thrombozytopenie
DK0830608T3 (da)	2000-11-20	Thromboseriskotest
EP1511854B1 (de)	2009-07-29	Hämatologisches bestimmungsverfahren und kit
JP2016194425A (ja)	2016-11-17	凝固時間の測定方法、ループスアンチコアグラントの存否の判定方法及びループスアンチコアグラント検出用試薬キット
JP2009058393A (ja)	2009-03-19	血液凝固測定用試薬及び血液凝固時間測定方法
DE59708506D1 (de)	2002-11-21	Verfahren zum durchführen von bluttests
ATE447717T1 (de)	2009-11-15	Verfahren zum nachweis eines prokoagulierenden phospholipids
EP1562047B1 (de)	2008-05-14	Reagenziensatz zum Nachweis von Lupus-Antikoagulant.
AU2015201260B2 (en)	2018-05-10	Composition for use as an abnormal coagulation control plasma in in vitro assays
WO2005111231A3 (en)	2006-07-06	Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities
JP4262550B2 (ja)	2009-05-13	ループスアンチコアグラント検出試薬キット
JPH07255497A (ja)	1995-10-09	凝固パラメーターの測定方法
DE60114443D1 (de)	2005-12-01	Verfahren zur identifizierung von listeria-monozytogenen und kulturmedium
WO1998049562A1 (de)	1998-11-05	Verfahren zum funktionellen nachweis von störungen im protein c-system
JP3833642B2 (ja)	2006-10-18	アンチトロンビン測定における特異性の改善
DE602006009567D1 (de)	2009-11-12	Verfahren und vorrichtung zur charakterisierung von ionenkanälen
ATE491945T1 (de)	2011-01-15	Verfahren zur bestimmung des vorhandenseins von thrombozyteninhibitoren in einer blutprobe

Legal Events

Date	Code	Title	Description
2010-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties